Armata Pharmaceuticals's total assets for Q4 2025 were $76.88M, a decrease of -14.11% from the previous quarter. DE:TG1N total liabilities were $295.48M for the fiscal quarter, a 59.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.